Vesigen Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Vesigen Therapeutics's estimated annual revenue is currently $8.4M per year.
- Vesigen Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Vesigen Therapeutics has 54 Employees.
- Vesigen Therapeutics grew their employee count by 10% last year.
Vesigen Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Vesigen Therapeutics?
Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables us to deliver a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells, expanding the universe of druggable targets. Our team is committed to leveraging ARMMs technology to enable new therapies and address currently unmet medical needs.
keywords:N/A
N/A
Total Funding
54
Number of Employees
$8.4M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.7M | 54 | -7% | N/A |
#2 | $8.7M | 54 | 8% | N/A |
#3 | $15.6M | 54 | 15% | N/A |
#4 | $4.2M | 54 | -21% | N/A |
#5 | $3.5M | 54 | -2% | N/A |